指南与共识肺结节与肺癌

2023年ACS指南新符合条件成人的肺癌筛查参与率与USPSTF符合条件成人的比较

Lung Cancer Screening Uptake Among Adults Newly Eligible Under the 2023 American Cancer Society Guideline Compared With US Preventive Services Task Force-Eligible Adults: A Nationwide Cross-Sectional Study.
指南 / 共识 · Chest · 2026-09-18

基于2024年全国健康访谈调查数据,分析50至80岁有吸烟史成人中,2023年ACS新扩展符合条件者与2021年USPSTF符合条件者的肺癌筛查参与率差异。结果显示ACS-only符合条件者过去12个月筛查率为8.0%,低于USPSTF符合条件者的17.8%,提示需针对远程戒烟史人群采取公平导向的筛查促进策略。

要点

  • ACS-only符合条件成人过去12个月肺癌筛查率为8.0%,不足USPSTF符合条件者17.8%的一半。
  • ACS-only符合条件与过去12个月筛查参与率升高相关(OR 1.62;95%CI 1.12-2.35)。
  • ACS-only组内非西班牙裔黑人和远程医疗使用与更高筛查参与率相关。

核心结论

  • 2023年ACS新纳入的成人过去12个月肺癌筛查参与率可测量,但仍不足USPSTF符合条件成人的一半。

研究设计与样本

  • 基于2024年全国健康访谈调查的横断面研究,纳入50至80岁有可计算包年史、当前或既往吸烟且无肺癌诊断的成人。

主要发现

  • 总体中35.2%为USPSTF符合条件,13.5%为ACS-only符合条件,51.2%为两者均不符合。
  • 过去12个月肺癌筛查率在USPSTF符合条件、ACS-only符合条件和两者均不符合组分别为17.8%、8.0%和3.9%。
  • 与两者均不符合相比,USPSTF符合条件与过去12个月筛查(OR 4.54;95%CI 3.44-5.98)和任何报告筛查(OR 3.44;95%CI 2.77-4.27)的更高 odds 相关。
  • ACS-only符合条件与过去12个月筛查的更高 odds 相关(OR 1.62;95%CI 1.12-2.35),但与任何报告筛查无显著关联。
  • 在ACS-only组内,非西班牙裔黑人和远程医疗使用与更高筛查参与率相关。

关键数值与推荐

  • USPSTF符合条件定义为≥20包年且戒烟<15年或当前吸烟。
  • ACS-only符合条件定义为≥20包年且戒烟>15年。

临床怎么用

  • 临床应关注既往吸烟且戒烟超过15年的人群,主动识别并推荐肺癌筛查。
  • 可考虑采用临床医生或系统触发的策略以提高ACS新符合条件人群的筛查参与率。
  • 针对非西班牙裔黑人及使用远程医疗的人群,可探索其筛查参与率较高的原因并推广有效模式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 2023 American Cancer Society (ACS) lung cancer screening (LCS) guideline expanded eligibility beyond the 2021 US Preventive Services Task Force (USPSTF) recommendations by removing the 15-year smoking cessation criterion. Screening uptake among adults newly eligible under ACS criteria remains unclear. RESEARCH QUESTION: How does LCS uptake among adults newly eligible under the 2023 ACS criteria differ from uptake among adults eligible under the 2021 USPSTF criteria? STUDY DESIGN AND METHODS: We analyzed 2024 National Health Interview Survey data for adults aged 50 to 80 years with a computable pack-year history, current or former smoking history, and no prior lung cancer diagnosis. Respondents were classified as USPSTF-eligible (≥ 20 pack-years, quit < 15 years ago, or currently smoke), ACS-only-eligible (≥ 20 pack-years or quit > 15 years ago), or neither-eligible. Outcomes were past-12-month and any reported LCS. Survey-weighted multivariable logistic regression estimated associations between eligibility group and screening uptake. RESULTS: The analytic sample included 5,987 adults, representing approximately 37.5 million US adults with a smoking history. Overall, 35.2% were USPSTF-eligible, 13.5% ACS-only-eligible, and 51.2% neither-eligible. Past-12-month LCS prevalence was 17.8%, 8.0%, and 3.9%, respectively. Compared with neither-eligible adults, USPSTF eligibility was associated with higher odds of both past-12-month LCS (OR, 4.54; 95% CI, 3.44-5.98) and any reported LCS (OR, 3.44; 95% CI, 2.77-4.27). ACS-only eligibility was associated with higher odds of past-12-month LCS (OR, 1.62; 95% CI, 1.12-2.35) but not any reported LCS. Within the ACS-only group, non-Hispanic Black race and telehealth use were associated with higher screening uptake. INTERPRETATION: Adults newly captured by the 2023 ACS criteria showed measurable past-12-month LCS uptake, but uptake remained less than one-half that of USPSTF-eligible adults. These findings suggest early implementation of broader ACS eligibility, while highlighting the need for equity-focused, clinician- or system-triggered strategies to identify people who formerly smoked with remote quit history.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Jia Y, Zhao J, Rivera MP, et al. Lung Cancer Screening Uptake Among Adults Newly Eligible Under the 2023 American Cancer Society Guideline Compared With US Preventive Services Task Force-Eligible Adults: A Nationwide Cross-Sectional Study. Chest. 2026. PMID: 42759647. doi:10.1016/j.chest.2026.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。